![]() |
市場調查報告書
商品編碼
1500381
Holter心電圖監測儀市場:按產品類型、導極類型和最終用戶分類 - 全球預測 2024-2030 年Holter ECG Market by Product (Software, Wired Holter ECG Monitors, Wireless Holter ECG Monitors), Lead Type (12-Lead, 3-Lead, 6-Lead), End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
Holter心電圖監測儀市場規模預計 2023 年為 4.4699 億美元,預計 2024 年將達到 4.7265 億美元,2030 年將達到 6.7603 億美元,複合年成長率為 6.08%。
Holter心電圖監測儀是醫生用來診斷和監測心律不整患者的醫療設備。這些設備連續記錄 24 至 48 小時的心電圖 (ECG) 訊號,以檢測需要進一步調查或治療的異常心率或心律不整。心血管疾病 (CVD) 的流行、心律不整風險增加的人口老化、遠端心臟監測技術的進步以及人們對早期診斷和預防保健措施的認知不斷提高,使得Holter心電圖監測儀 的正確診斷和治療方法變得更加重要。然而,Holter心電圖監測儀設備的高成本對小型醫療機構造成了財務障礙。用於遠端患者監護的遠距遠端醫療服務的快速採用也為Holter心電圖監測儀製造商創造了新的機會,以擴大其產品在全球的覆蓋範圍。
主要市場統計 | |
---|---|
基準年[2023] | 44699萬美元 |
預測年份 [2024] | 47265萬美元 |
預測年份 [2030] | 67603萬美元 |
複合年成長率(%) | 6.08% |
區域洞察
Holter心電圖監測儀市場正在美洲發展,由於人口老化和心臟病發病率增加,人們對心臟健康的興趣日益增加。我們致力於透過研究和技術投資來改善心臟護理,從而提高美洲的診斷能力。在歐盟 (EU),醫療保健提供者正在採用Holter心電圖監測儀等先進技術,透過早期檢測心臟疾病來改善患者的治療結果。在 EMEA(歐洲、中東和非洲)地區,隨著各國政府專注於發展醫療保健基礎設施和促進醫療旅遊,對先進醫療保健服務的需求正在快速成長。非洲人民越來越意識到預防心臟病的措施,增加了對包括心臟心電圖在內的診斷解決方案的需求。亞太地區專注於醫療設備的研究和開發,政府計劃和計劃強調心臟病早期診斷和干涉的重要性,導致我們在該地區的醫療機構中引入Holter心電圖監測儀。此外,技術進步和最尖端科技的整合預計將提高精度和準確度,加速全球最終用戶對Holter心電圖監測儀的使用。
FPNV定位矩陣
FPNV 定位矩陣對於評估Holter心電圖監測儀市場供應商的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對Holter心電圖監測儀市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該領域競爭性質的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在Holter心電圖監測儀市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[195 Pages Report] The Holter ECG Market size was estimated at USD 446.99 million in 2023 and expected to reach USD 472.65 million in 2024, at a CAGR 6.08% to reach USD 676.03 million by 2030.
Holter ECG is a medical device that enables physicians to diagnose and monitor patients with heart rhythm disorders. These devices continuously record electrocardiogram (ECG) signals for 24 to 48 hours to detect abnormal heartbeats or arrhythmias requiring further investigation and treatment. Prevalence of cardiovascular diseases (CVDs), increasing aging population with increased risk of arrhythmias, technological advancements in remote cardiac monitoring, and growing awareness regarding early diagnosis and preventive healthcare measures are raising the need for efficient medical devices, including holter ECG, for appropriate diagnosis and treatment. However, the high cost of Holter ECG devices can be a financial barrier for small-scale healthcare facilities. The surge in the adoption of telemedicine services in remote patient monitoring has also created new opportunities for Holter ECG manufacturers to expand their product reach worldwide.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 446.99 million |
Estimated Year [2024] | USD 472.65 million |
Forecast Year [2030] | USD 676.03 million |
CAGR (%) | 6.08% |
Regional Insights
The Holter ECG market is evolving in the Americas owing to the growing focus on cardiac health due to an aging population and increasing incidences of heart disease. Emphasis on improving cardiac care through investments in research and technology enhances diagnostic capabilities in the Americas. In the European Union, healthcare providers are adopting advanced technologies such as Holter ECG to improve patient outcomes by early detection of heart diseases. The EMEA region has experienced rapid growth in demand for advanced healthcare services with a focus on governments on healthcare infrastructure development and promoting medical tourism. There has been an increasing focus on creating awareness about preventive measures for cardiac conditions among the African population, raising the need for diagnostic solutions, including heart ECG. The APAC region is focusing on medical device research and development coupled with government schemes and programs emphasizing the importance of early diagnosis and intervention for cardiac conditions, which are expanding the deployment of Holter ECG in the healthcare facilities in the region. Besides, the technological advancements and integration of cutting-edge technologies are anticipated to enhance accuracy and precision, thereby accelerating the use of Holter ECG by end-users across the globe.
Market Insights
The market dynamics represent an ever-changing landscape of the Holter ECG Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Holter ECG Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Holter ECG Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
UltraLinQ to launch new cardiac monitoring product at Arab Health
Ultralinq announced the launch of ITS latest product in cardiac monitoring at Arab Health 2021. This innovative solution offers advanced and comprehensive Holter ECG monitoring for improved patient care. The state-of-the-art Holter ECG monitor can record and store up to 14 days of high-quality ECG data. Its user-friendly design simplifies the patient experience and reduces the time spent during clinic appointments. [Published On: 2023-01-13]
Xplore Lifestyle to launch CardiacSense, world's first medical grade watch to monitor the heart
Xplore Lifestyle introduced CardiacSense, the medical-grade watch for monitoring heart health. The device can record continuous Holter ECG (Electrocardiogram) for up to 48 hours. With this watch, users can track their heart rate and identify even minor irregularities in heart rhythms. Furthermore, it provides real-time monitoring of cardiovascular disease, arrhythmias, and other detected abnormalities in the heart. [Published On: 2022-07-27]
Three-lead Holter monitor for low-risk patients gains FDA 510(k) clearance
The FDA cleared a three-lead Holter monitor device by Biotricity for use in low-risk patients. This compact and lightweight Holter monitoring device is designed to provide high-precision ECG recordings, enabling effective diagnosis and treatment decisions. The clearance from the FDA affirms the device's safety and reliability, making it a trusted monitoring option in the United States. [Published On: 2022-01-25]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Holter ECG Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Holter ECG Market, highlighting leading vendors and their innovative profiles. These include AlivCor Inc., Bardy Diagnostics, Inc., BPL MEDICAL TECHNOLOGIES PRIVATE LIMITED, Cardiac Insight, Inc., custo med GmbH, EB Neuro S.p.A., Fukuda Denshi Co., Ltd., GE HealthCare Technologies Inc., Hill-Rom Holdings, Inc., iRhythm Technologies, Inc., Koninklijke Philips N.V., LifeSignals Group Inc., Medtronic plc, Nasiff Associates, Inc., Nihon Kohden Corporation, Nissha Co. Ltd., OSI Systems, Inc., SCHILLER AG, Viatom Technology Co. Ltd., and VitalConnect.
Market Segmentation & Coverage